Teva Pharmaceutical Industries Ltd (TEVA)
13.98
-0.10
(-0.71%)
USD |
NYSE |
May 03, 16:00
13.89
-0.09
(-0.64%)
Pre-Market: 09:25
Teva Pharmaceutical Industries Free Cash Flow: 842.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 842.00M |
| September 30, 2023 | 608.00M |
| June 30, 2023 | 1.173B |
| March 31, 2023 | 964.00M |
| December 31, 2022 | 1.042B |
| September 30, 2022 | 514.00M |
| June 30, 2022 | 476.00M |
| March 31, 2022 | 585.00M |
| December 31, 2021 | 236.00M |
| September 30, 2021 | 88.00M |
| June 30, 2021 | -131.00M |
| March 31, 2021 | -94.00M |
| December 31, 2020 | 638.00M |
| September 30, 2020 | 902.00M |
| June 30, 2020 | 894.00M |
| March 31, 2020 | 413.00M |
| December 31, 2019 | 223.00M |
| September 30, 2019 | -42.00M |
| June 30, 2019 | 84.00M |
| March 31, 2019 | 449.00M |
| December 31, 2018 | 1.795B |
| September 30, 2018 | 2.233B |
| June 30, 2018 | 2.534B |
| March 31, 2018 | 2.75B |
| December 31, 2017 | 1.351B |
| Date | Value |
|---|---|
| September 30, 2017 | 516.00M |
| June 30, 2017 | 1.173B |
| March 31, 2017 | 1.719B |
| December 31, 2016 | 2.989B |
| September 30, 2016 | 4.599B |
| June 30, 2016 | 4.282B |
| March 31, 2016 | 4.805B |
| December 31, 2015 | 4.77B |
| September 30, 2015 | 4.855B |
| June 30, 2015 | 5.144B |
| March 31, 2015 | 4.694B |
| December 31, 2014 | 4.198B |
| September 30, 2014 | 3.248B |
| June 30, 2014 | 2.252B |
| March 31, 2014 | 2.041B |
| December 31, 2013 | 2.206B |
| September 30, 2013 | 2.954B |
| June 30, 2013 | 3.537B |
| March 31, 2013 | 3.824B |
| December 31, 2012 | 3.468B |
| September 30, 2012 | 3.329B |
| June 30, 2012 | 2.736B |
| March 31, 2012 | 2.897B |
| December 31, 2011 | 3.081B |
| September 30, 2011 | 2.838B |
Free Cash Flow Range, Past 5 Years
-131.00M
Minimum
Jun 2021
1.173B
Maximum
Jun 2023
495.53M
Average
514.00M
Median
Sep 2022
Free Cash Flow Benchmarks
| Viatris Inc | 2.325B |
| Alvotech | -358.66M |
| AstraZeneca PLC | 5.785B |
| Corcept Therapeutics Inc | 126.90M |
| GSK PLC | 6.584B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.184B |
| Cash from Investing (Quarterly) | 301.00M |
| Cash from Financing (Quarterly) | -576.00M |
| Free Cash Flow Per Share (Quarterly) | 0.9517 |
| Free Cash Flow to Equity (Quarterly) | 1.206B |
| Free Cash Flow to Firm (Quarterly) | 1.327B |
| Free Cash Flow Yield | 5.37% |